Leo Wealth LLC’s Novo Nordisk NVO Stock Holding History

Leo Wealth LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,105	Closed	-$311K	–	472
2025 Q4	$311K	Buy	6,105 +1,762	+41%	+$90.1K	0.02%	340
2025 Q3	$241K	Sell	4,343 -1,312	-23%	-$76.8K	0.03%	254
2025 Q2	$390K	Buy	5,655 +2,040	+56%	+$139K	0.03%	273
2025 Q1	$251K	Sell	3,615 -2,086	-37%	-$172K	0.04%	238
2024 Q4	$490K	Buy	5,701 +101	+2%	+$10.9K	0.04%	236
2024 Q3	$667K	Sell	5,600 -156	-3%	-$20.8K	0.06%	192
2024 Q2	$827K	Buy	5,756 +144	+3%	+$19.1K	0.08%	163
2024 Q1	$719K	Buy	5,612 +664	+13%	+$79K	0.07%	178
2023 Q4	$565K	Buy	+4,948	New	+$489K	0.06%	192

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Leo Wealth LLC's NVO Position: Q1 2026 in Review

Leo Wealth LLC sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 6,105 shares — an estimated $311K sold.

Leo Wealth LLC first reported a position in NVO in Q4 2023 and held it in 9 quarters. The position peaked at $827K in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Leo Wealth LLC reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Leo Wealth LLC sold 6,105 Novo Nordisk shares in Q1 2026, an estimated $311K.
Leo Wealth LLC first reported a position in Novo Nordisk in Q4 2023 and held it in 9 quarters.
Leo Wealth LLC's Novo Nordisk position peaked at $827K in Q2 2024.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.